CERTERA – State Network Consortium for the Development of Advanced Therapy Drugs
Funds Source:
Government of Spain
Period:
01/05/2024 to 30/04/2026
Project typology:
Proyecto Consorciado
Project status:
ACTIVO
Funding Entity:
ISCIII
Funding:
10.000,00€
This project is part of the State Network Consortium for the Develoment of Advanced Therapy Medicines (CERTERA).
The participation is focused on the improvement of the productive systems of ATMPs (Advanced Therapy Medicinal Products) helping to design, implement and validate more robust, scalable, applying GMP(Good Management Practices)-Compliant concept and cost-effective bioprocesses. In short, the main objective of our approach is to help the members/users of the consortium to engineer and develop better bioprocesses yielding better products under controlled conditions. Our approach will also include the design, production and transfer to GMP production of non-viral vectors based on polymeric nanodelivery systems to be used in the production of ATMPs and also for gene therapy purposes. The non-viral vectors patented technology would be offered to other members/nodes of CERTERA consortium, to the clinical and research groups (users of CERTERA), and finally they will be used in house (at IQS) to transfect cells when requested to produce specific ATMP.
Research groups
GEMAT – Materials Engineering
The GEMAT group (Materials Engineering Group) conducts its activity in three main areas: the development of new functional materials, surface engineering and biomaterials.
EQBA – Electrochemistry and Bioanalysis Group
The group's activity is structured around the different analytical, spectrometric, chromatographic, electrochemical and optical techniques, both in their application and development.
GQBB – Biological and Biotechnological Chemistry
The GQBB group (Biological and Biotechnological Chemistry Group) conducts its activity in three main areas: identification and molecular analysis of proteins and enzymes, their use as therapeutic targets and design and applications of enzymes in biocatalysis and biotechnology in microorganisms.
GQF – Pharmaceutical Chemistry Group
The GQF group research focuses on two main areas: 1) The Pharmaceutical Chemistry Unit (new drugs)2) The Continuous Chemical Processes Unit